Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy

Epilepsia

Volumn 43, Issue 9, 2002, Pages 993-1000

  Brodie, Martin J ^a   Chadwick, David W ^b   Anhut, Henning ^c,d   Otte, Andreas ^c,d   Messmer, Silke Lo ^c,d   Maton, Stephen ^c,d   Sauermann, Wilhelm ^e   Murray, Guta ^c,d   Garofalo, Elizabeth A ^c,d  

^a WESTERN INFIRMARY   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c Parke Davis Pharmaceutical Research   (Germany)

^d PFIZER INC   (United States)

^e DATAMAP GmbH   (Germany)

Author keywords

Epilepsy; Gabapentin; Lamotrigine; Monotherapy; Noninferiority study

Indexed keywords

GABAPENTIN; LAMOTRIGINE;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; GRAND MAL EPILEPSY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; VERTIGO;

ACETIC ACIDS; ADOLESCENT; ADULT; AGED; AMINES; ANTICONVULSANTS; ASTHENIA; CLINICAL PROTOCOLS; CYCLOHEXANECARBOXYLIC ACIDS; DIZZINESS; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEADACHE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZINES;

EID: 0036711702     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.45401.x     Document Type: Article

References (21)

1. Early identification of refractory epilepsy
2. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
3. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
4. A double-blind, controlled clinical trial of oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
5. A double-blind controlled trial of oxcarbazepine versus phenytoin in adults with previously treated epilepsy
6. A double-blind, controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
7. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
8. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre, randomised, double-blind study
9. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
10. Gabapentin in generalised seizures
11. Proposal for revised clinical and electroencephalographic classification of epilepsy
12. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy
13. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin
14. Gabapentin monotherapy, I: An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures
15. Gabapentin monotherapy, II: A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures
16. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy
17. Gabapentin and cognition: A double-blind, dose-ranging, placebo-controlled study in refractory epilepsy
18. High dose gabapentin in refractory partial epilepsy: Clinical observations in 50 patients
19. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study
20. Effectiveness of first antiepileptic drug